Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial

BACKGROUND: Liver Transplantation (LT) is treatment of choice for patients with hepatocellular carcinoma (HCC) within MILAN Criteria. Tumour progression and subsequent dropout from waiting list have significant impact on the survival. Transarterial chemoembolization (TACE) controls tumour growth in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Katrin, Ganten, Tom, Gotthardtp, Daniel, Radeleff, Boris, Settmacher, Utz, Kollmar, Otto, Nadalin, Silvio, Karapanagiotou-Schenkel, Irini, von Kalle, Christof, Jäger, Dirk, Büchler, Markus W, Schemmer, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449604/
https://www.ncbi.nlm.nih.gov/pubmed/25957784
http://dx.doi.org/10.1186/s12885-015-1373-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449604/
https://www.ncbi.nlm.nih.gov/pubmed/25957784
http://dx.doi.org/10.1186/s12885-015-1373-z

Ejemplares similares